Sharon Benzeno, Chief Commercial Ofc Imm Med at Adaptive Biotechnologies Corp (ADPT), sold 1,212,804 shares at $16.91 ($20.3M) on 2025-11-21, disclosed to the SEC on 2025-11-24.
Scheduled sale ($20.3M) by Chief Commercial Ofc Imm Med under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.54 | 297,925 | $4.9M | 24.3% |
| 2 | $16.54 | 297,925 | $4.9M | 24.3% |
| 3 | $16.91 | 308,477 | $5.2M | 25.7% |
| 4 | $16.91 | 308,477 | $5.2M | 25.7% |
| Total | $16.73 avg | 1,212,804 | $20.3M | 100% |
| Filing → |
| ADPT | SELL | 2025-12-08 | $425K | — | Filing → |
| ADPT | SELL | 2025-03-06 | $312K | — | Filing → |
| ADPT | SELL | 2024-03-06 | $165K | — | Filing → |